SPDE (Speedus) DeferredTaxAndRevenue: $0.00 Mil (As of Sep. 2010)


What is Speedus DeferredTaxAndRevenue?

Speedus SPDE -99.00% DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2010.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Speedus's current deferred tax and revenue for the quarter that ended in Sep. 2010 was $0.00 Mil.

Speedus DeferredTaxAndRevenue Related Terms

Speedus DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Speedus's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Speedus DeferredTaxAndRevenue Chart

Speedus Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Speedus Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
Speedus (SPDE) has a DeferredTaxAndRevenue of $0.00 Mil as of Sep. 2010. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Speedus.
Is Speedus' DeferredTaxAndRevenue too high?
Speedus' current DeferredTaxAndRevenue is $0.00 Mil.
How does Speedus' DeferredTaxAndRevenue compare to LENSF and WHSI?
Speedus' DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Speedus. Speedus's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Speedus stock overvalued right now?
Speedus (SPDE) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Speedus (SPDE), the current DeferredTaxAndRevenue is $0.00 Mil as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Speedus Business Description

Address 1 Dag Hammarskjold Boulevard, Freehold, NJ, USA, 07728
Speedus Corp through its subsidiaries focuses on improving health outcomes and cost effectiveness through the development of computer-aided medical devices and telemedicine based delivery systems.